XTENT, Inc. Company Profile
Drugs and Medications
XTENT, Inc. develops customizable drug-eluting stent (DES) systems for the treatment of coronary artery disease. XTENT's customizable DES systems are designed to enable the treatment of single lesions...
The Foundry was co-founded in 1998 by Allan Will and Hanson Gifford, to rapidly turn the best concepts into successful new medical device companies. In addition to inventing new technologies itself, T...
More Information about "XTENT, Inc." on BioPortfolio
We have published hundreds of XTENT, Inc. news stories on BioPortfolio along with dozens of XTENT, Inc. Clinical Trials and PubMed Articles about XTENT, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of XTENT, Inc. Companies in our database. You can also find out about relevant XTENT, Inc. Drugs and Medications on this site too.